You can buy or sell Y-mAbs and other stocks, options, ETFs, and crypto commission-free!
Y-mAbs Therapeutics, Inc. Common Stock, also called Y-mAbs, is a clinical-stage biopharmaceutical company. Read More It develops novel antibody therapeutics for oncology targets. The company's services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in New York, NY.
New York, New York
52 Week High
52 Week Low
Yahoo FinanceMay 7
Here’s What Hedge Funds Think About Y-mAbs Therapeutics, Inc. (YMAB)
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Tiger Global because we determined that some of the stocks that they are collectively bullish on can help us generate returns above the broader indices.
-$0.47 per share